This article was originally published in The Gray Sheet
CaverMap surgical aid for use in sparing vital nerves during prostate surgery will be launched at the American Urological Association meeting in San Diego May 30-June 4. The Needham, Massachusetts firm begins a six-center clinical study involving over 100 patients designed to "quantify the benefits to patients and surgeons utilizing" the device, which received FDA clearance in October ("The Gray Sheet" Nov. 3, 1997, I&W-11)...
You may also be interested in...
Towa’s US-based Breckenridge is aiming for exclusivity with its generic version of Amgen’s Kyprolis – developed with partner Natco Pharma – after obtaining one of the first approvals for several strengths of the treatment for relapsed or refractory multiple myeloma.
As Nestlé continues to expand its presence in the VMS market it will not take a brand popular in one country and “force” that name on consumers in a different part of the world, says CEO Mark Schneider.
Lupin has claimed a first with a UK approval for a rival to Fostair. The Indian company has told Generics Bulletin that it is planning to roll out the Luforbec branded generic later this year.